Company Resonance Health Limited

Equities

RHT

AU000000RHT2

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 05:59:40 29/04/2024 BST			5-day change	1st Jan Change
0.081 ^AUD	-4.71%		0.00%	+35.00%

03:14am	Resonance Health's Cash Receipts Rise in Fiscal Q3	MT
04-02	Resonance Health to Acquire Clinical Research Company	MT

Resonance Health Limited is an Australia-based MedTech company. The Company specializes in the development and delivery of non-invasive medical imaging software and services. The Company is engaged in the development and commercialization of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. Its portfolio includes Core Lab and artificial intelligence (AI) powered products to partner with clinicians and radiologists for diagnosis, and management of patients in a variety of clinical settings. Its core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company's other SaMDs include Cardiac T2, for the assessment of iron in the heart, and HepaFat-Scan for the assessment of fat in and around the liver. The Company also has several AI-assisted SaMDs, including FerriSmart, HepaFat-AI, and LiverSmart.

AUD in Million	2022	Weight	2023	Weight	Delta
Services 100.0 %	4	100.0 %	4	100.0 %	+15.06%

AUD in Million	2022	Weight	2023	Weight	Delta
North America 63.1 %	3	67.3 %	3	63.1 %	+7.93%
EMEA 30.2 %	1	24.1 %	1	30.2 %	+44.52%
Asia/Pacific 6.7 %	0	8.6 %	0	6.7 %	-10.38%

Managers	Title	Age	Since
Andrew Harrison CEO	Chief Executive Officer	-	30/06/23
John Olynyk CTO	Chief Tech/Sci/R&D Officer	-	23/11/21
Mitchell Wells BRD	Director/Board Member	48	31/03/17
Sofie De Meyer PRN	Corporate Officer/Principal	-	31/12/21
Virginia Atkinson LAW	General Counsel	-	31/12/19
Liesl Ellies SEC	Corporate Secretary	-	28/04/22
Ajay Nair SAM	Sales & Marketing	-	27/07/21
Sherif Boulos PRN	Corporate Officer/Principal	-	-
Michael House PRN	Corporate Officer/Principal	-	-
Wenjie Pang PRN	Corporate Officer/Principal	-	31/12/04

Members of the board	Title	Age	Since
Mitchell Wells BRD	Director/Board Member	48	31/03/17
Martin Blake CHM	Chairman	-	03/10/07
Simon Panton BRD	Director/Board Member	-	04/10/09
Travis Baroni BRD	Director/Board Member	-	24/11/16
Aaron Brinkworth BRD	Director/Board Member	-	26/03/23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	466,892,928	267,866,092 ( 57.37 %)	0	57.37 %

Resonance Health Ltd.

141 Burswood Road Suite 2

6100, Burswood

http://www.resonancehealth.com

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
RESONANCE HEALTH LIMITED	+35.00%	24.77M
THERMO FISHER SCIENTIFIC	+8.83%	219B
DANAHER CORPORATION	+7.27%	183B
INTUITIVE SURGICAL, INC.	+11.08%	133B
BOSTON SCIENTIFIC CORPORATION	+25.58%	108B
SIEMENS HEALTHINEERS AG	+0.27%	63.06B
EDWARDS LIFESCIENCES CORPORATION	+12.98%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+3.96%	48.2B
AGILENT TECHNOLOGIES, INC.	+0.50%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+13.71%	39.35B

Other Advanced Medical Equipment & Technology